Avalo Therapeutics Inc (AVTX): Kapitalflussrechnung
Kennzahl in 1000 USD | TTM 2025-12-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 59 | 59 | 441 | 1.924 | 18.051 | 5.398 | 6.699 | 6.750,351 | 18.326,801 | 27.813,137 | 1.153 | 82,76 |
Cashflow aus operativer Geschäftstätigkeit | -14.246 | -51.458 | -49.056 | -30.680 | -26.751 | -70.892 | -40.539 | -19.134,332 | -3.128,102 | 12.519,405 | -14.573,138 | -9.288,215 |
▸ Operative Cashflow Marge | -24.145,76% | -87.216,95% | -11.123,81% | -1.594,59% | -148,2% | -1.313,3% | -605,15% | -283,46% | -17,07% | 45,01% | -1.263,93% | -11.223,07% |
Investitionsausgaben (CapEx) | - | - | - | 158 | 95 | 113 | 63 | 262,013 | 564,415 | 23,325 | 34,883 | 12,432 |
Cashflow aus Investitionstätigkeit | 2.401 | -81.720 | 356 | -133 | -95 | -113 | 11.132 | -443,002 | 865,461 | -18.912,257 | -34,883 | -12,432 |
Cashflow aus Finanzierungstätigkeit | 687 | 14.587 | 175.849 | 25.042 | -14.699 | 106.762 | 44.784 | 12.559,496 | 10.403,898 | 3.737,081 | -1.425,988 | 17.709,108 |
Freier Cashflow | -14.246 | -51.458 | -49.056 | -30.838 | -26.846 | -71.005 | -40.602 | -19.396,345 | -3.692,517 | 12.496,08 | -14.608,021 | -9.300,647 |
▸ Freie Cashflow Marge | -24.145,76% | -87.216,95% | -11.123,81% | -1.602,81% | -148,72% | -1.315,39% | -606,09% | -287,34% | -20,15% | 44,93% | -1.266,96% | -11.238,09% |
Ausgeschüttete Dividenden | - | - | - | - | -14.806 | -32.900 | - | -1.080,924 | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | -17 | 23 | 68 | 67 | 73 | 366 | -93,869 | -33,959 | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.